A cardiovascular device maker and a Denmark-based manufacturer are both considering local expansions.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
News
RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases
Company focused on editing the human leukocyte antigen (HLA) to transform autoimmunity Lead program, RG0401, in development for treatment-resistant or refractory rheumatoid arthritis (RA), as a one-time, curative treatment AURORA, Colo., Jan. 9, 2025 /PRNewswire/ […]
News
Post-Traumatic Growth: How to Flourish After a PTSD Diagnosis
No caring person would wish post-traumatic stress disorder (PTSD) – or the likely terrifying event that led to it – on anyone. But for those people who develop the mental health condition and find treatment, […]
News
Biodesix Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
BOULDER, Colo.–(BUSINESS WIRE)—- $BDSX #patientsfirst–Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the closing of its underwritten public offering of 35,075,000 shares of its common […]
